Raffles Medical Group Ltd
SGX:BSL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Raffles Medical Group Ltd
SGX:BSL
|
SG |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
Patriot Battery Metals Inc
ASX:PMT
|
CA |
|
Tower Bersama Infrastructure Tbk PT
IDX:TBIG
|
ID |
|
Aker ASA
OTC:AKAAF
|
NO |
|
T
|
Thai Beverage PCL
OTC:TBVPY
|
TH |
|
E
|
Electrocomponents PLC
LSE:ECM
|
UK |
Wall St Price Targets
BSL Price Targets Summary
Raffles Medical Group Ltd
According to Wall Street analysts, the average 1-year price target for BSL is 1.275 SGD with a low forecast of 1.212 SGD and a high forecast of 1.365 SGD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BSL's stock price target?
Price Target
1.275
SGD
According to Wall Street analysts, the average 1-year price target for BSL is 1.275 SGD with a low forecast of 1.212 SGD and a high forecast of 1.365 SGD.
What is the Revenue forecast for Raffles Medical Group Ltd?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Raffles Medical Group Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 8 years is 5%.
What is the Net Income forecast for Raffles Medical Group Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 8%.
